WuXi raises Se­ries B fund­ing

BioSpectrum (Asia) - - Start-Up-News -

WuXi Nex­tCODE, a global plat­form for ge­nomic data, has suc­cess­fully raised $240 mil­lion in Se­ries B fi­nanc­ing.

The com­pany ex­tended and com­pleted the Se­ries B round with in­vest­ment from a con­sor­tium led by Se­quoia China and in­clud­ing Te­masek, Yun­feng Cap­i­tal and 3W Part­ners.

Te­masek, Yun­feng and 3W also par­tic­i­pated in the ini­tial Se­ries B round in May along­side Am­gen Ven­tures and other ex­ist­ing long-term in­vestors and part­ners. China Re­nais­sance Group is the sole fi­nan­cial ad­vi­sor to WuXi Nex­tCODE in the lat­est fi­nanc­ing round.

The in­vest­ment will ac­cel­er­ate the growth of

WuXi Nex­tCODE’s plat­form in­fra­struc­ture and bring new users on­board through pre­ci­sion medicine and di­ag­nos­tics part­ner­ships. It also seeks to fur­ther com­mer­cial­ize its con­sumer so­lu­tions for the China mar­ket, ul­ti­mately en­abling in­di­vid­u­als to take charge of their own ge­nomic data and de­ploy it to ad­vance health and health­care.

Ge­nomics is an in­trin­si­cally global big data op­por­tu­nity of un­prece­dented scale, and with break­throughs in ar­ti­fi­cial in­tel­li­gence, there will be ex­plo­sive growth op­por­tu­ni­ties in the field of pre­ci­sion medicine.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.